Cannabinol Delays Symptom Onset In SOD1 (G93A) Transgenic Mice Without Affecting Survival

Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)

Key Findings

Treatment significantly delays disease onset by more than two weeks while survival was not affected.

Information and Links


Link: Cannabinol Delays Symptom Onset In SOD1 (G93A) Transgenic Mice Without Affecting Survival

Year: 2005

DOI: 10.1080/14660820510030149


Ratings

(How Ratings Work)

Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) — 2


Possible to probable range of efficacy of cannabis for treatment of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) according to the results found in this study.

Drugs Used

CBN was delivered via subcutaneously implanted osmotic mini-pumps (5 mg/kg/day) over a period of up to 12 weeks